Paroxetine is another very popular antidepressant, which is commonly known by its trade name known as Seroxat as well as Paxil. It is again of SSRI class and the marketing of such a drug commenced in the year 1992 by the establishment known as “Smith Kline Beecham”, and now this establishment is known by the name “Glaxo Smith Kline”. This drug is used in the treatment of major depressiveness, panic and also societal anxiety.
In the adults, the efficiency of this drug in the treatment of depression is almost comparable to the efficiency of old tricyclic drugs which were used in the treatment of depression with less side effects as well as low in the level of toxicity. The differences which are basically looked for between the older and the newer drugs are classified on the basis of side effects. Unlike sertraline, paroxetine is associated with a significant gain in the weight of the people.
Paediatric tests of paroxetine in the treatment of depression did not reflect the efficiency of the drug rather it reflected an increase in the level of risk associated with the intake of this drug such as suicidal demeanour as well as self harm are some prominent ones.
| | | |
|
